Benzydamine HCl , ≥97% , 132-69-4
Synonym(s):
1-Benzyl-3-(3-[dimethylamino]propoxy)-1H-indazole
CAS NO.:132-69-4
Empirical Formula: C19H23N3O.ClH
Molecular Weight: 345.87
MDL number: MFCD00078957
EINECS: 205-076-0
Pack Size | Price | Stock | Quantity |
1g | RMB28.80 | In Stock |
|
5G | RMB80.00 | In Stock |
|
25G | RMB222.40 | In Stock |
|
100G | RMB664.80 | In Stock |
|
500g | RMB2847.20 | In Stock |
|
others | Enquire |
PRODUCT Properties
Melting point: | 147-153°C |
storage temp. | Inert atmosphere,2-8°C |
solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) |
form | Solid |
color | White to Off-White |
Water Solubility | Soluble in water, ethanol, chloroform, n-butanol or DMSO
/n |
Merck | 14,1122 |
InChIKey | HNNIWKQLJSNAEQ-UHFFFAOYSA-N |
CAS DataBase Reference | 132-69-4(CAS DataBase Reference) |
Description and Uses
Benzydamine hydrochloride is a non-steroidal antiinflammatory drug used both topically and systemically. It has been reported as a sensitizer and a photosensitizer and caused occupational contact dermatitis in a nurse.
Benzydamine hydrochloride is an anti-in-flammatory drug used extensively in Europe and recently introduced in Canada to help re duce painful mucositis. Benzydamine provides short-term topical anesthesia and extended pain relief apparently through its anti-inflammatory properties. Studies have shown it to be effective in a range of painful conditions, including aphthous ulceration, chemotherapy-induced mucositis, and radiation-induced mucositis.
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H302-H319 |
Precautionary statements | P264-P270-P280-P301+P312-P305+P351+P338-P337+P313 |
Hazard Codes | Xn |
Risk Statements | 20/21/22-36 |
Safety Statements | 26-36 |
WGK Germany | 3 |
RTECS | NK7875000 |
HS Code | 2933.99.8290 |
Toxicity | LD50 in mice, rats (mg/kg): 110, 100 i.p.; 515, 1050 orally (Silvestrini) |